Takeda's Vedolizumab Demonstrated Robust Clinical Effectiveness and Safety in Inflammatory Bowel Disease in More Than 50 Real-World Studies
Allergan Enters Into Licensing Agreement with AstraZeneca to Obtain Worldwide Rights to Inflammatory Disorder Development Program
Aventis Energy Intersects Anomalous Radioactivity in Multiple Drill Holes at the Corvo Uranium Project and Concludes Inaugural Drill Program
